The collaboration between Leidos and the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) marks a significant step forward in the use of artificial intelligence in healthcare. The partnership, which involves a $10 million investment, aims to accelerate the development of AI-powered tools for detecting and managing diseases, such as heart disease and cancer.
The Challenges of Healthcare
The healthcare sector faces numerous challenges, including long diagnostic turnaround times, inadequate access to care, and a shortage of skilled healthcare professionals. These challenges can have significant consequences for patients, including delayed diagnosis, reduced treatment options, and decreased healthcare outcomes.
Leidos’ Commitment to Healthcare
Leidos has been committed to improving healthcare outcomes for over 25 years, through its work with the National Cancer Institute’s Frederick National Laboratory for Cancer Research. The company has also developed significant expertise in applying AI to healthcare, national security, and energy.
Key Objectives
The Leidos-University of Pittsburgh collaboration has several key objectives, including:
- Establishing a world-class research hub at the University of Pittsburgh to advance digital pathology and AI-driven diagnostics
- Developing digital health care solutions to support digital health and diagnostics
- Accelerating global impact by deploying AI-powered digital pathology solutions across public and private health care sectors
Research and Technology Development
The collaboration will focus on several critical areas, including:
- Joint research projects to explore new imaging methods, advanced scanning technologies, and improved techniques for analyzing medical images
- Workforce development and education programs to cultivate the next generation of healthcare and AI innovators
Workforce Development and Education
The initiative will provide comprehensive educational programs, including industry-focused best practices, annual symposiums, and hands-on internship opportunities. These programs will aim to cultivate the next generation of healthcare and AI innovators.
The collaboration is poised to have a significant impact on healthcare globally, through the deployment of AI-powered digital pathology solutions across public and private health care sectors.
“We want these tools to impact as many people as possible globally. Leidos can help get them into many more hands, ensuring that they are validated properly and get through the right regulatory frameworks,” said Hooman Rashidi, executive director of CPACE and associate dean of AI in medicine at the University of Pittsburgh School of Medicine. “The University of Pittsburgh’s leadership in research and innovation, coupled with the expertise in technology solutions offered by Leidos, establishes a path forward to delivering advancements in diagnosis, disease management, and healthcare delivery,” said Anantha Shekhar, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean, University of Pittsburgh School of Medicine.
Leidos is an industry and technology leader serving government and commercial customers, while the University of Pittsburgh School of Medicine is one of the nation’s leading academic centers for biomedical research.
| Company | Headquarters | Employees |
|---|---|---|
| Leidos | Reston, Virginia | 48,000 |
| University of Pittsburgh School of Medicine | Pittsburgh, Pennsylvania | N/A |
news is a contributor at Soozo. We are committed to providing well-researched, accurate, and valuable content to our readers.
